Australia launches 3D melanoma scanners to detect skin cancer early

Melanoma causes approximately 1,700 deaths annually in Australia, one of the world's highest rates, affecting over 28,000 newly diagnosed patients each year.
Melanoma is a deadly problem that demands disruptive solutions
The Australian Cancer Research Foundation is deploying 3D body scanners to transform how the country's deadliest skin cancer is detected.
Mark

Why does Australia have such a high melanoma death rate compared to other countries?

Mimi

The sun exposure is part of it—we're closer to the equator, the UV is intense, and there's a cultural history of outdoor living. But the real problem is that we've never had a standardized way to diagnose it. Doctors see what they see. There's no common language, no shared database, no way to learn from patterns across thousands of cases.

Mark

So these 3D scanners are basically creating that shared language?

Mimi

Exactly. They're not replacing doctors. They're giving doctors—and researchers—a way to see what's actually there, consistently, over time. A mole that looks the same to one person might show subtle changes when you have a precise 3D map from six months earlier.

Mark

And the algorithm part—that's the real game changer?

Mimi

That's where it could genuinely transform things. If you feed 100,000 detailed skin maps into a machine learning system, you might start seeing patterns that predict who will develop melanoma before they ever get sick. Right now we're reactive. This could make us predictive.

Mark

What happens to the 15,000 people in the study?

Mimi

They get scanned, their data goes into the national database, and researchers track them over five years. Some will develop skin cancer, some won't. That variation is exactly what teaches the algorithm what to look for.

Mark

Is there a risk that this becomes just another screening tool that finds things that wouldn't have killed you anyway?

Mimi

That's a fair question. But melanoma is different—it's aggressive, it spreads fast, and early detection genuinely changes outcomes. The billion dollars a year we're already spending on skin cancer treatment suggests we're not catching things early enough now.

  • Australia diagnoses more than 28,000 melanoma cases each year with no standardized method of detection, leaving patients and clinicians navigating one of the world's deadliest skin cancer rates without a common map.
  • Fifteen 3D body scanners are being activated across three states, capable of capturing the entire surface of a person's skin and tracking subtle changes in moles that the human eye would never catch in time.
  • A national database of up to 100,000 patient images is being assembled over five years, with researchers feeding that data into predictive algorithms designed to identify who is at risk before any visible symptoms emerge.
  • The scanning network deliberately reaches into regional Queensland and rural New South Wales, addressing the quiet crisis of communities where specialist dermatology has long been out of reach.
  • With skin cancer already costing the healthcare system over a billion dollars annually, early detection is framed not only as a medical imperative but as an economic and human one — catching disease when it is still simple to treat.

Australia carries one of the world's heaviest burdens of melanoma — a disease that claims roughly 1,700 lives each year despite affecting a country long accustomed to its dangers. In a nation where diagnosis has never been standardized, 15 three-dimensional body scanners are now being deployed across Queensland, New South Wales, and Victoria, inviting 15,000 citizens into a five-year effort to map human skin at a scale never before attempted here. The ambition is not merely to detect cancer sooner, but to learn to see it coming — to transform melanoma from a discovery made too late into a risk identified before harm is done.

Australia's relationship with melanoma is one of grim familiarity. More than 28,000 people are diagnosed each year, and around 1,700 die — a mortality rate that ranks among the worst in the world. What makes this harder to accept is that, until now, there has been no standardized way to diagnose the disease. That is beginning to change.

The Australian Cancer Research Foundation is deploying 15 three-dimensional body scanners across Queensland, New South Wales, and Victoria. The machines map the entire surface of a person's skin in fine detail, creating a record that can be revisited over time. A mole that appeared stable months ago might reveal subtle shifts invisible to the naked eye. Tracked alongside thousands of similar cases, patterns emerge that no individual clinician could ever perceive alone.

The larger goal is a national database of up to 100,000 patient images, gathered over five years from 15 scanning sites. Researchers intend to use that data to build algorithms capable of predicting melanoma risk before symptoms appear — a fundamental shift from reacting to disease to anticipating it. University of Queensland dermatology professor Peter Soyer described it as a bold initiative with genuine potential; the foundation's chief executive called melanoma a deadly problem that demands disruptive solutions.

The sites span urban hospitals and regional centres alike — from Cairns and Mount Isa in Queensland to Dubbo in New South Wales and Bendigo in Victoria — deliberately reaching communities where specialist care has historically been scarce. The 15,000 Australians who participate in the coming weeks are doing more than joining a study. They are helping lay the foundation for a future in which melanoma is no longer a disease discovered when it is already dangerous, but a risk that medicine learns, at last, to see coming.

Australia has a melanoma problem that kills faster than most countries can explain. More than 28,000 people are diagnosed with the disease each year, and roughly 1,700 of them die from it—a mortality rate that ranks among the world's worst. Yet despite how common melanoma is here, there has never been a standardized way to diagnose it. That gap is about to narrow. Starting Monday, the first wave of 15,000 Australians will walk into 3D body scanners being deployed across Queensland, New South Wales, and Victoria. The machines, rolled out by the Australian Cancer Research Foundation, do something straightforward but powerful: they map the entire surface of a person's skin, creating a detailed three-dimensional record that can be compared over time. A mole that looked stable six months ago might show subtle changes invisible to the naked eye. A spot that seemed harmless might be tracked alongside thousands of others to reveal patterns no single doctor could ever see.

The real ambition lives in what comes next. Researchers plan to build a national database containing up to 100,000 patient images collected over five years from 15 state-of-the-art scanning sites. The goal is to feed that data into algorithms that can predict who will develop melanoma or other skin cancers before symptoms appear. If it works, it would be transformative—a shift from waiting for cancer to show itself to identifying risk before the disease takes hold. Peter Soyer, a dermatology professor at the University of Queensland, called it a bold initiative that could genuinely improve how early melanoma is caught and treated. Kerry Strydom, chief executive of the Australian Cancer Research Foundation, was more direct: melanoma is a deadly problem that demands disruptive solutions.

The scanners are being installed at 16 locations across the three states. In Queensland, six sites will operate: Cairns, the Sunshine Coast, Royal Brisbane Women's Hospital, Townsville, and Mount Isa. New South Wales is getting five: Westmead Hospital, the Melanoma Institute Australia, Royal Prince Alfred Hospital, Dubbo, and a combined Port Macquarie and Coffs Harbour site. Victoria will have five as well, including the Alfred Hospital, the Skin Health Institute, Bendigo Health, the Peter MacCallum Cancer Centre, and Bass Coast. The geographic spread matters. It reaches into regional areas where access to specialist dermatology is thin, and it covers major urban centers where patient volume is highest.

The stakes are not abstract. Skin cancer treatment already costs the Australian healthcare system more than a billion dollars annually. That figure captures not just the direct cost of surgery and chemotherapy, but the lost productivity, the follow-up appointments, the complications that ripple through people's lives. Early detection doesn't just save lives—it saves money, reduces suffering, and catches disease when treatment is simpler and more effective. The 15,000 Australians who step into these scanners over the coming weeks are not just participating in a study. They are helping build the evidence base for a new way of thinking about melanoma: not as a disease you discover when it's already dangerous, but as a risk you can see coming.

Melanoma is a deadly problem that needs disruptive solutions
— Kerry Strydom, chief executive of the Australian Cancer Research Foundation
This bold initiative will allow us to really improve the early detection and treatment of melanoma
— Peter Soyer, dermatology professor at the University of Queensland
Envie de l'histoire complète ? Lire l'original sur The Canberra Times ↗
Nous contacter FAQ